KLRK1 and neoplasm: The strong expression of NKG2D in both the NKG2D-NK and IL24-NKG2D-NK groups indicates that these cells are well suited for further investigation into their potential therapeutic applications, particularly in terms of tumor recognition and immune response modulation.